Mutagenic analysis of the platelet thromboxane A2(TXA2) receptor with platelet dysfunction characterized by the absence of TXA2-induced platelet aggregation in spite of normal TXA2 binding activity.

被引：0
|
作者：
Fuse, I [1 ]
Higuchi, W [1 ]
Sato, N [1 ]
Seki, Y [1 ]
Aizawa, Y [1 ]
机构：
[1] Niigata Univ, Sch Med, Dept Internal Med 1, Niigata, Japan
来源：
THROMBOSIS AND HAEMOSTASIS | 1999年
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1566
引用
收藏
页码：497 / 497
页数：1
相关论文
共 50 条
  • [41] Local anesthetic effects on TXA2 receptor mediated platelet aggregation using quenched flow aggregometry
    Honemann, CW
    Lo, B
    Erera, JS
    Polanowska-Grabowska, R
    Gear, ARL
    Durieux, M
    EICOSANOIDS AND OTHER BIOACTIVE LIPIDS IN CANCER, INFLAMMATION AND RADIATION INJURY, 4, 1999, 469 : 269 - 276
  • [42] Diversity of signaling underlying responses mediated by selective activation of the platelet thromboxane A2 (TXA2) receptor;: pharmacological and kinetic studies in vitro
    Maayani, S
    Schwarz, TE
    Patel, ND
    Craddock-Royal, BD
    Tagliente, TM
    PLATELETS, 2003, 14 (06) : 359 - 374
  • [43] DDAVP normalized the bleeding time in patients with congenital platelet TxA2 receptor abnormality
    Fuse, I
    Higuchi, W
    Mito, M
    Aizawa, Y
    TRANSFUSION, 2003, 43 (05) : 563 - 567
  • [44] PLATELET TXA2 SYNTHESIZING ACTIVITY IN ISCHEMIC HEART-DISEASE AND EFFECT OF TICLOPIDINE
    KAWAGOE, S
    SEINO, Y
    TEI, H
    MUNAKATA, J
    YAMAGUCHI, A
    TANOUE, K
    YAMAZAKI, H
    THROMBOSIS AND HAEMOSTASIS, 1985, 54 (01) : 67 - 67
  • [45] EFFECTS OF BERBERINE ON SYNTHESIS OF PLATELET TXA2 AND PLASMA PGI2 IN RABBITS
    HUANG, CG
    CHU, ZL
    YANG, ZM
    ACTA PHARMACOLOGICA SINICA, 1991, 12 (06) : 526 - 528
  • [46] IMPAIRED PLATELET RESPONSE TO THROMBOXANE-A2 (TXA2) AND DEFECTIVE CALCIUM MOBILIZATION IN A PATIENT WITH A BLEEDING DISORDER
    LAGES, B
    MALMSTEN, C
    WEISS, HJ
    SAMUELSSON, B
    CIRCULATION, 1980, 62 (04) : 104 - 104
  • [47] Thromboxane A2 (TXA2) receptor antagonist improves exercise tolerance in patients with COPD
    Inoue, T
    Mori, M
    Matsubara, H
    Oguma, T
    Okubo, Y
    Shiomi, T
    Tateno, H
    Meguro, Y
    Yamaguchi, K
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A802 - A802
  • [48] CHARACTERIZATION OF THROMBOXANE A2 PROSTAGLANDIN H-2 (TXA2/PGH2) RECEPTORS OF RAT PLATELETS AND THEIR INTERACTION WITH TXA2/PGH2 RECEPTOR ANTAGONISTS
    HANASAKI, K
    ARITA, H
    BIOCHEMICAL PHARMACOLOGY, 1988, 37 (20) : 3923 - 3929
  • [49] EFFECTS OF PLATELET-ACTIVATING-FACTOR ANTAGONISTS ON ARACHIDONIC ACID-INDUCED PLATELET-AGGREGATION AND TXA2 FORMATION
    HEINROTHHOFFMANN, I
    HAUSER, A
    MEST, HJ
    PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 1990, 41 (03): : 181 - 182
  • [50] SYNERGY BETWEEN A TXA2-RECEPTOR BLOCKING DRUG AND TXA2 SYNTHASE INHIBITOR UPON COLLAGEN-INDUCED PLATELET-AGGREGATION - A COMPARISON BETWEEN SPECIES
    PIKE, NB
    WHARTON, KA
    WATTS, IS
    LUMLEY, P
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 1082 - 1082
12345